Here are five insights:
1. Adin develops, manufactures and sells products and services in the dental field, offering technological solutions to customers worldwide.
2. The licensing agreement identifies three major dental applications for DSG, estimating a potential for 8 million dental procedures.
3. Other terms of the agreement include technology transfer, product development support, milestones and royalty payments.
4. Pierre Jérôme, CEO and co-founder of SpineGuard, said, “This licensing agreement is a big step forward for SpineGuard as it demonstrates the potential for our DSG technology beyond spine surgery.”
5. Eyal Milman, CEO and co-founder of Adin, said, “This collaboration with SpineGuard is an important step toward making this innovative technology accessible to Adin’s patients and [physicians].”
More articles on devices and implants:
Global orthopedic devices market to hit $58.8B by 2023 – 8 observations
Medtronic, DePuy Synthes, Smith & Nephew & more: 14 device company key notes
Zimmer Biomet introduces X-PSI Knee System – 5 points
